Sugi Predict

Sugi Predict / Compounds / SCHEMBL23723006

SCHEMBL23723006

SCHEMBL23723006

N[C@](F)(C(=O)O)C(F)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 2/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ SRC P12931 1/20 0.40
▸ EPHX1 P07099 1/20 0.39
▸ LMNA P02545 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HDAC3 O15379 2/20 0.39
▸ HDAC4 P56524 2/20 0.39
▸ HDAC1 Q13547 2/20 0.39
▸ HDAC6 Q9UBN7 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ CTSD P07339 1/20 0.38
▸ GRM2 Q14416 2/20 0.38
▸ GRM3 Q14832 2/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ CES2 O00748 1/20 0.38
▸ CES1 P23141 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26664904 0.85 ESR1 (0.45) SRCLMNAHIF1A
SCHEMBL29009915 0.79 CYP2D6 (0.43) CYP2D6CYP1A2SRCLMNAMAPK1
SCHEMBL6438147 0.78 CYP2C19 (0.44) CYP2D6CYP1A2SRCEPHX1LMNA
SCHEMBL25408725 0.78 GAA (0.44) CYP2D6CYP1A2HDAC3HDAC4HDAC1
SCHEMBL1516480 0.73 CYP2D6 (0.38) CYP2D6CYP1A2SRCLMNAMAPK1
SCHEMBL25367722 0.73 CYP2D6 (0.38) CYP2D6CYP1A2SRCLMNAMAPK1
SCHEMBL9348120 0.73 SRC (0.40) CYP2D6SRCLMNASMN1; SMN2CYP2C19
SCHEMBL11112546 0.72 CYP2C19 (0.36) CYP2D6CYP1A2SRCEPHX1LMNA
SCHEMBL28774583 0.72 SLC6A4 (0.41) CYP2D6SRCLMNAMAPK1
SCHEMBL16428390 0.72 PTPN1 (0.38) CYP2D6SRCLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3966226-B1 MASP INHIBITORY COMPOUNDS AND USES THEREOF BAYER AG (DE) 2025-12-24 — — EP disclosed
US-12503491-B2 MASP inhibitory compounds and uses thereof BAYER AKTIENGESELLSCHAFT (DE) 2025-12-23 — — US disclosed
US-20240124522-A1 MASP INHIBITORY COMPOUNDS AND USES THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2024-04-18 — — US disclosed
US-11667675-B2 MASP inhibitory compounds and uses thereof BAYER AKTIENGESELLSCHAFT (DE) 2023-06-06 — — US disclosed
US-20210246166-A1 MASP INHIBITORY COMPOUNDS AND USES THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2021-08-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12503491-B2 MASP inhibitory compounds and uses thereof MASP2, SERPINB1, SPINT2 CYP2D6 4444/4885CYP1A2 4511/4885SRC 3066/4885
US-11667675-B2 MASP inhibitory compounds and uses thereof MASP2, SERPINB1, SPINT2 CYP2D6 4444/4885CYP1A2 4511/4885SRC 3066/4885
US-20240124522-A1 MASP INHIBITORY COMPOUNDS AND USES THEREOF MASP2, SERPINB1, SPINT2 CYP2D6 4444/4885CYP1A2 4511/4885SRC 3066/4885
US-20210246166-A1 MASP INHIBITORY COMPOUNDS AND USES THEREOF MASP2, SERPINB1, SPINT2 CYP2D6 4444/4885CYP1A2 4511/4885SRC 3066/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.